Citadel Advisors’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129K Buy
+10,600
New +$145K ﹤0.01% 11812
2025
Q2
Sell
-4,900
Closed -$83.9K 12722
2025
Q1
$83.9K Sell
4,900
-700
-13% -$13K ﹤0.01% 11704
2024
Q4
$108K Buy
5,600
+1,500
+37% +$28.3K ﹤0.01% 11370
2024
Q3
$75.8K Sell
4,100
-7,300
-64% -$136K ﹤0.01% 11468
2024
Q2
$214K Sell
11,400
-3,800
-25% -$67.9K ﹤0.01% 9781
2024
Q1
$262K Buy
15,200
+11,600
+322% +$195K ﹤0.01% 9760
2023
Q4
$62.6K Sell
3,600
-11,300
-76% -$188K ﹤0.01% 11538
2023
Q3
$255K Sell
14,900
-4,200
-22% -$69.5K ﹤0.01% 9468
2023
Q2
$289K Buy
19,100
+14,000
+275% +$196K ﹤0.01% 9124
2023
Q1
$69.5K Sell
5,100
-3,100
-38% -$44.9K ﹤0.01% 11744
2022
Q4
$105K Buy
+8,200
New +$111K ﹤0.01% 11151

Other funds holding CCAP

Citadel Advisors's CCAP Position: Q1 2026 in Review

Citadel Advisors sold out of Crescent Capital BDC (CCAP) in Q1 2026, closing a stake of 34,215 shares — an estimated $468K sold.

Citadel Advisors first reported a position in CCAP in Q3 2020 and held it in 16 quarters. The position peaked at $2.53M in Q1 2023. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.

  • Citadel Advisors reported no remaining Crescent Capital BDC position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 34,215 Crescent Capital BDC shares in Q1 2026, an estimated $468K.
  • Citadel Advisors first reported a position in Crescent Capital BDC in Q3 2020 and held it in 16 quarters.
  • Citadel Advisors's Crescent Capital BDC position peaked at $2.53M in Q1 2023.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.